Anika WehrleTomasz M. WitkosSheila UngerJudith SchneiderJohn A. FollitJohannes HermannTim WeltingVirginia FanoMarja HietalaNithiwat VatanavicharnKatharina SchonerJürgen SprangerMiriam SchmidtsBernhard ZabelGregory J. PazourAgnes Bloch-ZupanGen NishimuraAndrea Superti-FurgaMartin LoweEkkehart LauschUniversité de StrasbourgUniversität Freiburg im BreisgauCentre Hospitalier Universitaire VaudoisMaastricht UniversityHopital CivilMahidol UniversityPhilipps-Universität MarburgCHU StrasbourgTurun yliopistoUniversity of ManchesterFundacion Hospital de Pediatria Professor Dr. Juan P. GarrahanUniversity of Massachusetts Medical SchoolTokyo Metropolitan Kiyose Children’s Hospital2020-01-272020-01-272019-02-07JCI Insight. Vol.4, No.3 (2019)237937082-s2.0-85069212446https://repository.li.mahidol.ac.th/handle/20.500.14594/51873© Copyright 2019, American Society for Clinical Investigation. Odontochondrodysplasia (ODCD) is an unresolved genetic disorder of skeletal and dental development. Here, we show that ODCD is caused by hypomorphic TRIP11 mutations, and we identify ODCD as the nonlethal counterpart to achondrogenesis 1A (ACG1A), the known null phenotype in humans. TRIP11 encodes Golgi-associated microtubule-binding protein 210 (GMAP-210), an essential tether protein of the Golgi apparatus that physically interacts with intraflagellar transport 20 (IFT20), a component of the ciliary intraflagellar transport complex B. This association and extraskeletal disease manifestations in ODCD point to a cilium-dependent pathogenesis. However, our functional studies in patient-derived primary cells clearly support a Golgi-based disease mechanism. In spite of reduced abundance, residual GMAP variants maintain partial Golgi integrity, normal global protein secretion, and subcellular distribution of IFT20 in ODCD. These functions are lost when GMAP-210 is completely abrogated in ACG1A. However, a similar defect in chondrocyte maturation is observed in both disorders, which produces a cellular achondrogenesis phenotype of different severity, ensuing from aberrant glycan processing and impaired extracellular matrix proteoglycan secretion by the Golgi apparatus.Mahidol UniversityMedicineArticleSCOPUS10.1172/jci.insight.124701